ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
32 announcements with these filters
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Amanta Healthcare held its 31st Annual General Meeting on September 16, 2026, transacting ordinary and special business items via video conferencing.
Amanta Healthcare has commenced production at its new SteriPort facility at the Kheda campus. This brownfield expansion aims to improve operational efficiency and EBITDA margins.
Amanta Healthcare Ltd has provided a web-link for shareholders to access the Annual Report and Notice of the 31st Annual General Meeting.
Amanta Healthcare Limited has scheduled its 31st Annual General Meeting for September 16, 2026. Key agenda items include adopting financial statements and revising the Managing Director's remuneration.
Amanta Healthcare Limited has issued a notice for its 31st Annual General Meeting scheduled for September 16, 2026. Key agenda items include adopting financial statements and auditor appointments.
Amanta Healthcare Limited has released its Annual Report for FY 2025-26. The company will hold its 31st Annual General Meeting on September 16, 2026, via video conferencing.
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
Amanta Healthcare reported Q1FY27 revenue of Rs.68.8 Crore with EBITDA of Rs.15.2 Crore. Profitability was impacted by higher finance costs for new projects.
Amanta reported Q1FY27 revenue of INR 69 Cr (5% YoY) with 21% EBITDA margins. Strategy focuses on high-margin SteriPort/SVP capacity expansion and cost optimization via solar power.
Amanta Healthcare Limited submitted the Statement of Deviation in fund utilization for the quarter ended June 30, 2026, confirming no deviation in usage of IPO proceeds.
Amanta Healthcare Ltd reported revenue from operations of ₹68.8 Cr (+5.4% YoY) and net profit of ₹3.3 Cr (-5.7% YoY) for Q1 FY27.
Amanta Healthcare Ltd has appointed Mr. Nilesh Punjabi as Assistant Vice President (HR & Admin) and Senior Management Personnel, effective August 5, 2026.
Amanta Healthcare has scheduled a board meeting on August 5, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Amanta Healthcare Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI (LODR) Regulations.
Promoter Bhavesh G Patel acquired 1,000 shares from Kirit Desai via off-market transfer for ₹0.0016 Crore. The acquisition occurred on June 30, 2026.
Promoter Bhavesh Girishbhai Patel acquired 1,000 shares via an off-market inter-se transfer. The transaction value totaled 0.016 Crore at the specified price.
Amanta Healthcare successfully commissioned a 10.8 MWp solar plant for captive consumption. The facility became operational on May 30, 2026, aimed at reducing long-term operational costs.
Amanta Healthcare Limited submitted its Annual Secretarial Compliance Report for FY2026. The report by M/s. Kashyap R. Mehta and Partners confirms overall regulatory compliance with SEBI norms.
Amanta Healthcare Limited confirmed zero deviation in utilizing ₹126 Crore raised via its IPO. Funds were deployed towards capital expenditure and general corporate purposes.
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.
Amanta Healthcare approved a remuneration hike for MD Shri Bhavesh Patel to ₹13.29 Lakh monthly. The revision, effective April 2026, awaits shareholder approval via special resolution.
Amanta Healthcare appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditor for five years. Internal and Cost Auditors were also re-appointed for FY 2026-27.
Amanta Healthcare reported FY26 revenue of ₹287.68 Crore and 42% YoY profit growth. The company is currently executing major capacity expansions to drive sustainable future growth.
Amanta Healthcare reported FY26 revenue of ₹288 Cr (+5% YoY) and PAT of ₹15 Cr (+42% YoY), driven by improved margins and reduced finance costs.
Amanta Healthcare Ltd reported revenue from operations of ₹77 Cr (+6.8% YoY) and net profit of ₹5.5 Cr (-8.3% YoY) for Q4 FY26.
Amanta Healthcare reported a total income of ₹291.05 Crore for FY26. The Board also updated policies for insider trading and whistleblowers.
Amanta Healthcare scheduled a board meeting on May 19, 2026, to approve audited FY26 financial results. Trading window remains closed until May 22.
Amanta Healthcare clarified that promoter Shri Bhavesh Patel acquired an additional 15,500 shares on March 30, 2026. This credit follows a prior acquisition of 13,300 shares, increasing his total holding to 63,26,544 shares (16.29%).
Amanta Healthcare Ltd clarified that promoter Shri Bhavesh Patel's share acquisition was partially rejected due to technical reasons. Only 13,300 shares were credited out of the intended 28,800. Consequently, his post-transaction holding stands at 63,11,044 shares (16.25%). This update corrects the company's previous disclosure dated April 1st, 2026.